Zhejiang Hisoar Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.20%

Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has an Asset Resilience Ratio of 0.20% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Zhejiang Hisoar Pharmaceutical Co Ltd (002099) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥14.71 Million

≈ $2.15 Million USD Cash + Short-term Investments

Total Assets

CN¥7.28 Billion

≈ $1.06 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2024)

This chart shows how Zhejiang Hisoar Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Hisoar Pharmaceutical Co Ltd (002099) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Hisoar Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002099 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥14.71 Million	0.2%
Total Liquid Assets	CN¥14.71 Million	0.20%

Asset Resilience Insights

Limited Liquidity: Zhejiang Hisoar Pharmaceutical Co Ltd maintains only 0.20% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Hisoar Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Hisoar Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Hisoar Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.60%	CN¥45.03 Million ≈ $6.59 Million	CN¥7.46 Billion ≈ $1.09 Billion	+0.49pp
2021-12-31	0.12%	CN¥9.48 Million ≈ $1.39 Million	CN¥8.02 Billion ≈ $1.17 Billion	-2.01pp
2018-12-31	2.13%	CN¥150.00 Million ≈ $21.95 Million	CN¥7.04 Billion ≈ $1.03 Billion	+1.46pp
2017-12-31	0.67%	CN¥50.00 Million ≈ $7.32 Million	CN¥7.47 Billion ≈ $1.09 Billion	+0.67pp
2014-12-31	0.00%	CN¥119.75K ≈ $17.52K	CN¥4.17 Billion ≈ $609.83 Million	-0.04pp
2011-12-31	0.04%	CN¥561.04K ≈ $82.10K	CN¥1.44 Billion ≈ $210.01 Million	-0.02pp
2006-12-31	0.05%	CN¥500.00K ≈ $73.17K	CN¥921.93 Million ≈ $134.91 Million	-0.08pp
2005-12-31	0.14%	CN¥800.00K ≈ $117.07K	CN¥576.72 Million ≈ $84.39 Million	-0.01pp
2004-12-31	0.15%	CN¥576.32K ≈ $84.33K	CN¥387.38 Million ≈ $56.69 Million	-1.14pp
2003-12-31	1.29%	CN¥4.67 Million ≈ $683.58K	CN¥362.38 Million ≈ $53.03 Million	--

pp = percentage points

About Zhejiang Hisoar Pharmaceutical Co Ltd

SHE:002099 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.18 Billion

CN¥8.06 Billion CNY

Market Cap Rank

#8341 Global

#2035 in China

Share Price

CN¥4.98

Change (1 day)

-3.11%

52-Week Range

CN¥4.98 - CN¥8.83

All Time High

CN¥11.31